El Instituto Nacional de Salud ha desarrollado
el proceso de adaptación de guías de práctica
clínicas (GPC) a fin de proveer de un documento científico como herramienta útil para
los profesionales de la salud y contribuir en la
mejora de la salud del país.
La presente guía de práctica clínica e...
Geraghty, Robert M;
Davis, Niall F;
Tzelves, Lazaros;
Lombardo, Riccardo;
Yuan, Cathy;
Thomas, Kay;
Petrik, Ales;
Neisius, Andreas;
Türk, Christian;
Gambaro, Giovanni;
Skolarikos, Andreas;
Soman, Bhaskar K.
The European Association of Urology (EAU) has updated its guidelines on clinical best practice in urolithiasis for 2021. We therefore aimed to present a summary of best clinical practice in surgical intervention for patients with upper tract urolithiasis. The panel performed a comprehensive literature re...
A group of experts from different disciplines was convened to develop guidelines for the management of upper visual field impairments related to eyelid ptosis and dermatochalasis. The goal was to provide evidence-based recommendations to improve patient care.
A multidisciplinary group of experts represen...
García Martín, Antonia;
Alhambra Expósito, María Rosa;
Cortés Berdonces, María;
Jódar Gimeno, Esteban;
Huguet, Isabel;
Rozas Moreno, Pedro;
Varsavsky, Mariela;
Ávila Rubio, Verónica;
Muñoz Garach, Araceli;
Muñoz Torres, Manuel.
Objective: To provide practical recommendations for the management of mineral and bone metabolism alterations in pregnancy and lactation. Participants: Members of the Working Group on Osteoporosis and Mineral Metabolism of the Spanish Society of Endocrinology and Nutrition.
Methods: Recommendations were ...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at reducing...
A Grading of Recommendations, Assessment, Development and Evaluation (GRADE) review of the evidence for benefits and harms for Moderna coronavirus disease 2019 (COVID-19) vaccine for persons aged 12-17 years was presented to the Advisory Committee for Immunization Practices (ACIP) on June 23, 2022. GRADE...
A Grading of Recommendations, Assessment, Development and Evaluation (GRADE) review of the evidence for benefits and harms for Moderna coronavirus disease 2019 (COVID-19) vaccine for children aged 6–11 years was presented to the Advisory Committee for Immunization Practices (ACIP) on June 23, 2022. GRA...
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CD...
